Core Viewpoint - HYTN Innovations Inc. has appointed Mr. Fabian Monaco to its Board of Directors, bringing significant experience in technology entrepreneurship and capital markets to support the company's growth strategy [1][2][3]. Company Overview - HYTN Innovations Inc. is a pharmaceutical manufacturer specializing in cannabis, focusing on the formulation, manufacturing, marketing, and sale of products containing psychoactive and psychotropic compounds [6]. Appointment of Mr. Fabian Monaco - Mr. Monaco has a proven track record in building high-growth businesses and has extensive experience in venture capital, private equity, and public markets, particularly in software and fintech [2]. - He previously served as the CEO of Gage Growth Corp., which was acquired for over $500 million in 2022, and under his leadership, Gage achieved $100 million in revenue with over 15 retail locations and 350 employees [2]. Strategic Growth and Marketing Initiatives - Mr. Monaco expressed enthusiasm about joining HYTN at a pivotal stage, highlighting the company's differentiated strategy and potential for growth [3]. - The CEO of HYTN emphasized that Mr. Monaco's combination of entrepreneurial success and capital markets expertise aligns well with the company's growth strategy [3]. - The company has extended its engagement with MCS Market Communication Service GmbH to provide marketing and communications services, expected to commence on March 23, 2026, for approximately 60 days [3][4]. Marketing Services Details - MCS will develop digital content, advertising materials, and execute keyword optimization and media distribution services to enhance awareness of HYTN and its business [4]. - The total compensation for MCS's services is set at €100,000, with no securities issued as compensation [5].
HYTN Appoints Fabian Monaco to Board of Directors
Globenewswire·2026-03-20 21:30